Indication
Esophageal candidiasis
Esophageal candidiasis is an opportunistic fungal infection of the esophageal mucosa, representing the most common cause of infectious esophagitis. Read more about Esophageal candidiasis
137 drugs 87 manufacturers
Drugs that treat it
Common Esophageal candidiasis therapies.
FLUCONAZOLE
ERAXIS (anidulafungin)
FLUCONAZOLE-NACL (fluconazole in sodium chloride, iso-osmotic)
FLUCONAZOLE
FLUCONAZOLE
ERAXIS (anidulafungin)
MICAFUNGIN (micafungin sodium)
MICAFUNGIN (micafungin sodium)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonEsophageal candidiasis is an opportunistic fungal infection of the esophageal mucosa, representing the most common cause of infectious esophagitis.
Primarily caused by *Candida albicans*, it typically affects immunocompromised populations, including individuals with advanced HIV infection, hematologic malignancies, or diabetes, as well as patients receiving systemic corticosteroids, chemotherapy, or broad-spectrum antibiotics.
The condition occurs when impaired host defenses permit fungal proliferation and tissue invasion, leading to the formation of characteristic diffuse, creamy white mucosal plaques that can progress to ulcerations.
Hallmark clinical manifestations include odynophagia, dysphagia, and retrosternal chest pain, often occurring alongside oropharyngeal candidiasis.
- nih.gov
Esophageal candidiasis is an opportunistic fungal infection of the esophageal mucosa, representing the most common cause of infectious esophagitis Primarily caused by *Candida albicans*, it typically affects immunocompromised populations, including individuals with advanced HIV infection, hematologic malignancies, or diabetes, as well as patients receiving systemic corticosteroids, chemotherapy, or broad-spectrum antibiotics The condition occurs when impaired host defenses permit fungal prolifer...
- nih.gov
Esophageal candidiasis is an opportunistic fungal infection of the esophageal mucosa, representing the most common cause of infectious esophagitis Primarily caused by *Candida albicans*, it typically affects immunocompromised populations, including individuals with advanced HIV infection, hematologic malignancies, or diabetes, as well as patients receiving systemic corticosteroids, chemotherapy, or broad-spectrum antibiotics The condition occurs when impaired host defenses permit fungal prolifer...
- hiv.gov
The condition occurs when impaired host defenses permit fungal proliferation and tissue invasion, leading to the formation of characteristic diffuse, creamy white mucosal plaques that can progress to ulcerations
- nih.gov
Hallmark clinical manifestations include odynophagia, dysphagia, and retrosternal chest pain, often occurring alongside oropharyngeal candidiasis
Personalize your experience
Follow Esophageal candidiasis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.